Texas Instruments: Not Aggressive Enough

By @ibtimes on

Texas Instruments out with pretty good commentary. They raised their fourth quarter net outlook but it wasn't that much and the stocks had a new high so you need more aggressive ... - CNBC's Squawk on the Street 12/9/2009

Normally, when a company decides to go above and beyond the quarterly reporting and offer a mid-quarter conference call and lift guidance, it demands a bullish reaction from the market. However, after the close on Tuesday, Texas Instruments (TXN) management gave investors a view into their thus far solid quarter and the stock has sold off in reaction. TI narrowed the revenue and earnings guidance to the high side of the previous range, but neglected to raise the guidance substantially. For the third quarter, they expect sales of $2.90 billion to $3.02 billion, which improved from the previous forecast of $2.78B to $3.02B. Earnings per share should come in between $.47 and $.51 versus previous ranges of $.42 to $.50. TXN

Even though the guidance was slightly better than consensus analysts' estimates, there was nothing to really excite investors in the announcement and TXN has sold off nearly 2.5% as a result. Analysts have been raising estimates over the last few months because of the improved environment for chip stocks. So many investors were expecting Texas Instruments to show improvement that this appears to be a standard case of buy the rumor and sell the news. This same sort of thing happened for TXN nearly six months ago when the company reported an earnings beat and raised guidance following the fiscal first quarter.

The stock was trading near its 52-week high so clearly expectations were high, but at the currently price level and valuation are not a concern at this point. We currently have a Fairly Valued stance on TXN, even as this year's sales have been weaker than we would have liked to see. TI did say that it expects sales growth in a number of end markets for its chips such as cell phones, and that demand is currently outpacing supply. These factors should lead to somewhat improved sales going forward, but supply constraints may keep growth moderate. Based on what the market has historically been willing to pay for a given level of revenue and cash earnings, our methodology suggests that anywhere in the range of $19 to $27 would be appropriate given current fundamentals. Based on this neutral valuation, we are not recommending buying shares at the current levels, and we can only imagine this sort of thing is getting pretty annoying to TI's investors.

Join the Discussion